Page last updated: 2024-11-08

metyrapol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

metyrapol: reduction product of metyrapone with sodium borohydride; RN given refers to unlabeled cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161210
CHEMBL ID933
CHEBI ID172467
MeSH IDM0042695

Synonyms (14)

Synonym
CHEBI:172467
17159-42-1
2-methyl-1,2-dipyridin-3-ylpropan-1-ol
metyrapol
CHEMBL933 ,
2-methyl-1,2-bis(3-pyridyl)-1-propanol
bdbm50028160
2-methyl-1,2-di-pyridin-3-yl-propan-1-ol
metyrapol (mpol)
2-methyl-1,2-di(pyridin-3-yl)propan-1-ol
su-5236
AKOS030241945
DTXSID10938007
A904438

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 11B1, mitochondrial Bos taurus (cattle)IC50 (µMol)7.05000.00101.06087.8300AID3091
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (1)

Processvia Protein(s)Taxonomy
glucocorticoid biosynthetic processCytochrome P450 11B1, mitochondrial Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
iron ion bindingCytochrome P450 11B1, mitochondrial Bos taurus (cattle)
heme bindingCytochrome P450 11B1, mitochondrial Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID427879Displacement of [3H]ethynylpropylbicycloorthobenzoate from GABA receptor from rat cortical membrane at 100 uM by scintillation counting in absence of GABA2009Bioorganic & medicinal chemistry letters, Aug-01, Volume: 19, Issue:15
Structure-activity relationship of etomidate derivatives at the GABA(A) receptor: Comparison with binding to 11beta-hydroxylase.
AID427878Displacement of [3H]ethynylpropylbicycloorthobenzoate from GABA receptor from rat cortical membrane at 100 uM by scintillation counting in presence of 1 uM GABA2009Bioorganic & medicinal chemistry letters, Aug-01, Volume: 19, Issue:15
Structure-activity relationship of etomidate derivatives at the GABA(A) receptor: Comparison with binding to 11beta-hydroxylase.
AID1134142Inhibition of bovine adrenal gland 11beta-hydroxylase assessed as inhibition of [14C]-deoxycorticosterone hydroxylation at 2 uM relative to metyrapone1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
New inhibitors of steroid 11beta-hydroxylase. Structure--activity relationship studies of metyrapone-like compounds.
AID3091Evaluated for inhibition of bovine adrenal cortical mitochondrial 11 beta-hydroxylase1984Journal of medicinal chemistry, Jan, Volume: 27, Issue:1
Structure-activity relationship study of the inhibition of adrenal cortical 11 beta-hydroxylase by new metyrapone analogues.
AID1134141Inhibition of bovine adrenal gland 11beta-hydroxylase assessed as inhibition of [14C]-deoxycorticosterone hydroxylation at 2 uM1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
New inhibitors of steroid 11beta-hydroxylase. Structure--activity relationship studies of metyrapone-like compounds.
AID327555Displacement of [131I]IMTO from CYP450c 11 in Wistar rat adrenal membrane2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
New selective inhibitors of steroid 11beta-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (25.00)18.7374
1990's7 (43.75)18.2507
2000's4 (25.00)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.42 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]